Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12180196-B2 · Dec 31, 2024 · US
Indirubin derivative having highly selective cytotoxicity for malignant tumors
US9051306B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9051306-B2 |
| Application number | US-201214232836-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 5, 2012 |
| Priority date | Jul 15, 2011 |
| Publication date | Jun 9, 2015 |
| Grant date | Jun 9, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An agent for treating malignant tumors based on a new mechanism is provided, which comprises an indirubin derivative represented by formula (1) or a salt thereof: wherein A represents an alkylene group having 1 to 4 carbon atoms, and R 1 to R 4 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, or an alkoxy group.
First claim
Opening claim text (preview).
The invention claimed is: 1. An indirubin derivative of formula (1) or a salt thereof: wherein A is an alkylene group having 1 to 4 carbon atoms, and R 1 to R 4 are each independently a hydrogen atom, a halogen atom, a hydroxy group, or an alkoxy group. 2. The indirubin derivative or a salt thereof according to claim 1 , wherein A is a methylene g…
Assignees
Inventors
Classifications
- C07D405/14Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9051306B2 cover?
- An agent for treating malignant tumors based on a new mechanism is provided, which comprises an indirubin derivative represented by formula (1) or a salt thereof: wherein A represents an alkylene group having 1 to 4 carbon atoms, and R 1 to R 4 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, or an alkoxy group.
- Who is the assignee on this patent?
- Suzuki Takashi, Miyairi Shinichi, Saito Hiroaki, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification C07D405/14. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).